Director David Scott Moore buys 21,700 shares of CRVS at $11.53; stock down 55.8% from 52-week high amid ongoing losses.
Director David Scott Moore purchased 21,700 shares at $11.53 on 2026-06-11, establishing a non-derivative position of 21,700 shares while retaining 15,000 shares in stock options (Table II derivative holdings). The buy occurs in a depressed context: the stock trades 55.8% below its 52-week high of $26.95, down 23.0% over the prior 90 days, and the company posted a net loss of $-13.7M in its most recent full fiscal year. The purchase represents a material commitment ($250.2K) by a director into a company experiencing significant revenue headwinds and unprofitability, suggesting directional conviction at current valuation levels. With derivative holdings intact, this represents a selective accumulation of non-derivative equity rather than a blanket portfolio bet, and the 90-day decline provides the context for this entry timing.